Biocon Limited has informed the Exchange regarding a press release dated February 24, 2025, titled "Biocon Biologics Launches Yesintek (ustekinumab-kfce) Biosimilar to Stelara? in the United States".
Biocon Limited has informed the Exchange regarding a press release dated February 24, 2025, titled "Biocon Biologics Launches Yesintek (ustekinumab-kfce) Biosimilar to Stelara? in the United States".